glp 1 drugs and cancer InsideHSC News Do GLP-1 drugs cause cancer?
Description
In addition, the drug combination also had no effect on the intestinal microbiome in elderly patients with T2DM, but there was an increase in the percentage of bacteria of the genus Alistipes
Gilbert, Rosenthal, March 2024
Slowing Down Digestion: These injections activate receptors in the stomach to slow the digestion process, which helps in better nutrient absorption and reduces post-meal glucose spikes, contributing to gradual blood sugar levels and aiding in weight management
Thirdly, GLP-1 agonists slow gastric emptying, leading to a delayed absorption of nutrients and a prolonged feeling of fullness, which can contribute to reduced food intake and weight loss
Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R
Tirzepatide follows a similar pattern, with indications spanning glycemic control and obesity treatment
